Alaunos Therapeutics, Inc. (TCRT) › Shareholders' EquityAlaunos Therapeutics, Inc. (TCRT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2003: $340.0K2004: -$144.0K2005: $7.20M2006: $26.53M2007: $30.37M2008: $6.74M2009: $28.10M2010: $30.55M2011: $71.61M2012: $48.45M2013: $49.38M2014: $33.84M2015: $87.37M2016: -$77.30M2017: -$96.81M2018: $85.56M2019: $95.01M2020: $123.98M2021: $58.06M2022: $38.55M2023: $6.31M2024: $2.06M2025: $2.15M$2.15M2003Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$2.15M+4.4%2024$2.06M-67.3%2023$6.31M-83.6%2022$38.55M-33.6%2021$58.06M-53.2%2020$123.98M+30.5%2019$95.01M+11.0%2018$85.56M+188.4%2017-$96.81M-25.2%2016-$77.30M-188.5%2015$87.37M+158.2%2014$33.84M-31.5%2013$49.38M+1.9%2012$48.45M-32.3%2011$71.61M+134.4%2010$30.55M+8.7%2009$28.10M+317.0%2008$6.74M-77.8%2007$30.37M+14.5%2006$26.53M+268.4%2005$7.20M+5101.4%2004-$144.0K-142.4%2003$340.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share